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Background: The effects of performing a minimally invasive procedure at different stages after intracerebral
hemorrhage on perihematomal MMP-9 expression and blood–brain barrier (BBB) permeability were evaluated.
Methods: Sixty rabbits were randomly distributed into a model control group (MC group, 30 rabbits) or a minimally
invasive group (MI group, 30 rabbits). A model of intracerebral hemorrhage was established in the MC and MI
group. In the MI group, the intracerebral hematoma was evacuated by stereotactic minimally invasive procedures
over 6 hours (6 rabbits), 12 hours (6 rabbits), 18 hours (6 rabbits) 24 hours or 48 hours (6 rabbits) following
successful induction of intracerebral hemorrhage. The same procedure was performed in the MC group at the
same time point but without evacuating the hematoma. All the animals were sacrificed within two weeks after the
hematoma was surgically evacuated. A neurological deficit score was determined, and the perihematomal MMP-9
level and the BBB permeability were measured.
Results: The neurological deficit score, perihematomal MMP-9 level and BBB permeability of the MI group decreased
significantly compared to the MC group. Performing the MI procedure 6–12 h after intracerebral hemorrhage showed
the most favorable outcome.
Conclusions: Regarding the pathophysiological changes surrounding the hematoma, the optimal time window of
performing MI procedures for the intracerebral hematoma evacuation might be within 6–12 h after hemorrhage.
Keywords: Cerebral hemorrhage, Minimally invasive procedures, MMP-9, Blood brain barrier, Neurological deficit scoreBackground
Spontaneous intracerebral hemorrhage (ICH) remains
the least treatable form of stroke. It is associated with high
rates of morbidity and mortality. Evidence-based medical
therapies for ICH are limited to recommendations on
blood pressure reduction, intracranial pressure monitoring,
osmotherapy with adequate fluid resuscitation, fever and
glycemic control, and seizure prophylaxis [1]. Surgical ap-
proaches for managing ICH include traditional open surgi-
cal removal of the hematoma, endoscopic evacuation of
the hematoma [2,3], key-hole craniotomy and minimally
invasive stereotactic puncture and thrombolysis therapy
[4]. Although the efficacy of surgical treatment of ICH* Correspondence: wuguofeng3013@sina.com
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unless otherwise stated.remains unproven and controversial [5], and open surgery
does not appear to improve the patient’s outcome, less
invasive methods of hematoma evacuation seem to show
promising results in improving patient outcome and sur-
vival [5]. Minimally invasive stereotactic puncture and
thrombolysis therapy have emerged as a promising man-
agement strategy for ICH patients [4,6]. Recently pub-
lished studies have demonstrated that minimally invasive
procedures can successfully evacuate intracerebral hema-
tomas and improve the outcome of patients [2,4,5,7-11].
The advantages of minimally invasive stereotactic punc-
ture therapy are safety, and seemed to be feasible and to
had a trend towards improved long-term outcome [4].
However, although the minimally invasive stereotactic
puncture and thrombolysis therapy has displayed favorable
outcomes, the effect of such procedure for ICH evacuation
on perihematomal brain tissues remains elusive. The. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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imally invasive surgery is under investigation. Clinically,
the early stage (within 7–24 h) was found to be the opti-
mal time-window for surgical intervention of spontaneous
ICH [12]. However, these results are based on clinical
observations. The selected indices could not reflect the
perihematomal pathophysiological changes.
The initial onset of ICH is always followed by a peri-
hematomal brain edema formation which causes a sec-
ondary brain damage, leading to significant neurological
deterioration [9]. The perihematomal brain edema forma-
tion after ICH is associated with blood–brain barrier
(BBB) disruption induced by a range of factors, including
matrix metalloproteinases and the excitatory neurotrans-
mitter glutamate [10,13-15].
Matrix metalloproteinases (MMPs) have been demon-
strated to be associated with BBB disruption after ICH
[16-19]. The role of MMPs in hemorrhagic stroke ap-
pears critical for hematoma and brain edema growth as
well as for neuronal death, which are understood as
secondary brain injury and may have a considerable
clinical impact [20]. Inhibition of MMP activity by using
pharmacological anti-MMPs strategies may provide an
approach to reduce ongoing edema after ICH [19]. How-
ever, attempts at MMP inhibition in spontaneous ICH
have solely been made under experimental conditions
and were associated with a wide range of possible side
effects [20]. Reducing the release of MMP-9 by minim-
ally invasive stereotactic puncture and thrombolysis for
ICH evacuation might be another choice. The perme-
ability of BBB decreased as MMP-9 expression decreased
after intracerebral hematomas were evacuated by a minim-
ally invasive procedure [10]. However, the effects of min-
imally invasive procedures performed at different stages of
intracerebral hematoma evacuation on MMP-9 levels and
their correlation with the perihematomal BBB permeability
have been poorly investigated.
The purpose of the present study was to provide
pathophysiological evidences for an optimal time win-
dow of the minimally invasive stereotactic puncture and
thrombolysis ICH evacuation by investigating the effects
of performing such procedures at different stages on
MMP-9 changes and their correlation with the perihe-




The following reagents were used in this study: TRIZOL
reagent, chloroform, isopropyl alcohol, 100% ethanol, 75%
ethanol, RNA enzyme-free water, RNA enzyme-free
glycogen, TE (10 mM, Tris–HCl pH 8, 1 mM EDTA)
(Tris–HCl, EDTA), 0.4 M MOPS, pH 7.0 (MOPS),
0.1 M sodium acetate, 0.01 M EDTA, Brominated bpounds and AGAR sugar were provided by Sangong
Biotech (Shanghai) Co., Ltd; SuperScript. III First-Strand
Synthesis System (Invitrogen), Hot Start Fluorescent
PCR Core Reagent Kits (BIO BASIC INC, SYBR Green I),
Formamide (molecular formula: HCONH2, Chongqing
Chuanjiang Chemical Reagent Factory), urethane (mo-
lecular formula: C3H7NO2, Wuxi Yangshan Biochem-
ical), Evans blue (Beijing Hengye Zhongyuan Chemical),
4% paraformaldehyde (Wuhan Boster Biological Technol-
ogy), urokinase (Guangdong Livzon Pharmaceutical)
were used in this study.
Instruments
For this study, we used the following instruments: a ZH-
Lanxing B-Type rabbit stereotaxic Apparatus (Huaibei
Zhenghua Biological Instrument & Equipment), electronic
scales (Satourious, Germany), a Rainbow Type-722 grating
spectrophotometer (Shandong Gaomi Rainbow Analytical
Instrument), a 5415R high-speed centrifuge (Frozen,
Heraeus Company), micropipettors (Eppendorf), a 202–2
constant temperature oven (Shanghai Luda Laboratory
Apparatus), a digital display thermostat water bath HH-2
(Guohua Electric Appliance), a desktop general centri-
fuge (TGL-16B; Shanghai Anting Scientific Instrument
Factory), a −80°C freezer (Forman Scientific Company),
a refrigerator (Qingdao), a CT provided by the Guiyang
Medical College, a G1315 A diode-array detector (DAD,
Agilent Technologies, USA), a pH meter (410 A, ORION,
USA), an Agilent 1313A Automatic Sampler (Agilent
Technologies, USA), a column oven (Agilent Technolo-
gies, USA), scales (Beijing Gangdong Hengye Instrument),
Fluorescence quantitative PCR instrument (ABI 7500
Fast), Polymerase chain reaction (PCR) amplification
instrument (BBI Canada), SW-CJ-1 D clean bench (Jiangsu
Sue clean the equipment factory), DK-8 D type the
electrical thermostatic sink (Shanghai Senxin Experi-
ment Instrument Co., LTD), DYY-8 voltage type stablized
electrophoresis apparatus (Shanghai Qi’s Analysis Instru-
ment Co., LTD), YXJ-2 centrifuge (Hunan Instrument
Centrifuge Instrument Co., LTD), H6-1 miniature electro-
phoresis slot (Shanghai Lean Organic Glass Instrument
Plant); Gel imaging system (Gene Genius), U-3010 UV–
vis spectrophotometer (Hitachi), Removing liquid device
(range 100–1000 ml, 20–200 ml, 0.5–10 ml) (Canada
BBI), and Primer design software: Primer Premier 5.0.
Experimental groups
The present study was approved by the Animal Care
and Use Committee of Guiyang Medical College.
Sixty male rabbits (2.8–3.4 kg) were provided by the
Animal Center of Guiyang Medical College. These rab-
bits were randomly assigned to a model control group
(MC group, including 30 rabbits), or a minimally inva-
sive treatment group (MI group, including 30 rabbits).
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The method used to prepare an ICH model was the same
as that used in our previously published studies [10,21,22].
Briefly, the rabbits were fastened to the stereotaxic appar-
atus. The head was then adjusted to make bregma 1.5 mm
higher than the lambdoid suture. The skull of the rabbit
was drilled, and using a #12 needle and a 1-ml syringe,
0.5 ml autologous arterial blood was taken from the cen-
tral ear artery. The syringe was then connected to a #7
needle from which the tip was removed. The #7 needle
was then inserted vertically and quickly into the skull
12 mm deep, and the blood was slowly injected into the
basal ganglia. A CT scan was performed 3 hours later. A
high-density shadow in the basal ganglia region with no
shadow in the lateral ventricle was considered to be suc-
cessful ICH induction (Figure 1A).
The rabbits were sent back to the animal room and
housed as usual after successful ICH induction confirmed
by CT scan. All of the animals recovered from anesthesia
within 5 hours after intravenous injection of 20% ureth-
ane. The total anesthesia time was 3–5 hours.
The exclusion criteria included visualization of back
flow along the needle track, blood in the ventricle, and
death of the rabbit.
Evaluation of the ICH volume
At 3 days after the ICH model was established, a CT
scan in all the rabbits was performed again to demonstrate
the efficacy of the surgical procedures. The volume of
ICH was calculated using the Tada formula [π /6 × length
(cm) × width (cm) × height (cm)] before MI surgery.
Histological sections were prepared in all animals toFigure 1 Brain CT showing changes of intracranial hematoma
before and after the minimally invasive procedures. A: Basal
ganglia hematoma was observed after the ICH model was prepared
successfully. B: The intracerebral hematoma disappeared after the MI
procedures were performed.observe the hematoma volume when the rabbits were
sacrificed two weeks after the minimally invasive sur-
gery was performed.
Minimally invasive procedures for ICH evacuation
The rabbits from the MI and MC groups were anesthe-
tized again by injecting 20% urethane (5 ml/kg) into the
ear vein. They were then placed in the stereotaxic appar-
atus, a #7 needle was inserted into the hematoma.
In MI group the liquid part of the hematoma was aspi-
rated. We then injected 5,000 U of urokinase (dissolved
in 0.5 ml of 0.9% sodium chloride solution) into the
hematoma. The needle was kept in place for 15 min,
followed by slow aspiration while withdrawing the nee-
dle. The rabbits were then placed back in the breeding
room for two weeks.
A CT scan was performed again three days after the
surgical procedures to demonstrate the efficacy of min-
imally invasive procedures.
Procedures performed in the MI group were also per-
formed in the MC group, but just with a sham evacu-
ation without aspirating the hematoma, and without
injecting the urokinase into the hematoma.
Medical treatment of the animals
Animals in each group only received an intramuscular
injection of penicillin (400,000 U) to prevent infection,
and they were housed as usual until they were sacrificed.
No other medical treatment was administered.
Neurological deficit score measurement
A neurological deficit scale was used to determine neuro-
logical function between groups [23]. The scale included
tests of motor function (1–4), consciousness (1–4), head
turning (0–1), circling (0–1) and hemianopsia (0–1). A
total score of 11 indicates maximum impairment (co-
matose or dead rabbit), whereas 2 denotes complete
normality. Tests were conducted by an observer blinded
to the animals.
Brain tissues preparation
Two weeks after the hematoma was evacuated by the
MI procedures, the animals were sacrificed to obtain
the brain tissues for detecting the MMP-9 and the EB
content. The brain was then extracted and placed on
ice. Using the needle track as the center to prepare a
coronal section and a sagittal section, then the brain
on the hematoma side was cut and divided into four
parts: anterior-inner, anterior-outside, posterior-inner
and posterior-outside. A total of 5 mm of brain tissue
surrounding the hematoma was collected from each
part mentioned above. The anterior-inner part was
used for MMP-9 mRNA detection and was stored
at −80°C. The anterior-outside part was used for
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inner part and posterior-outside parts were used for
testing the water content in the brain.
Real Time-PCR for MMP-9 mRNA detection
The animals were sacrificed, and the brains were re-
moved. Brain samples (approximately 50 mg) extracted
from the anterior-outside part of the hematoma were
pulverized [24], and total RNA was isolated using TRIzol
reagent. cDNAs were generated from 8 μl (0.5 μg/μl) of
total RNA by Superscript II RNase H- reverse transcript-
ase primed with oligo (dT) 1 μl (0.5 μg/μl). All primers
for MMP-9, β-actin and the PCR protocol were designed
as follows: MMP9-F: 5′ACTTCCAACTTTGACAGCGA
C3′ (Tm= 56.9), MMP9-R: 5′-GAGTGATCCAAGCCCA
GTG3′ (Tm = 55.4 110 bp); β-actin primers: 5′-GGTCAT
CACCATCGGCAAC3′ (Tm= 58.7), β-actin: 5′-ATGTCC
ACGTCGCACTTCA 3′ (Tm = 57.4 129 bp). Multitarget
PCRs were performed by coamplifying β-actin as an
internal standard. The reaction component included
Hotstart fluo-PCR mix 12.525 μl, primer F 0.5 μl, pri-
mer R 0.5 μl, ddH20 9.5 μl and cDNA 2 μl. The reac-
tion was performed at 95°C for 2 min per 1 cycle.
Each of 40 cycles included 95°C, 10 s; 58°C (β-actin)
and 56°C (MMP-9), 30 s, and 68°C, 40 s.
A ΔCt value was used to determine the relative quan-
tity of MMP-9 mRNA. The ΔCt value reflects the differ-
ence between the value of sample mRNA expression and
the R-β-actin mRNA expression. The greater the ΔCt
value is, the less the sample mRNA.
The BBB permeability measurement
Evans blue was used as a tracer to measure the BBB per-
meability. Two hours before each experiment, 2% Evans
blue (2 ml/kg) was injected into the ear vein. After 2 h,
the brain tissue was quickly removed. The tissue sur-
rounding the hematoma was weighed (with an accuracy
of 0.1 mg) and then placed into a test tube with 4 ml of
formamide. The tube was then capped and placed in a
54°C water bath for 24 h to allow the Evans blue to
spread throughout the brain tissue. The samples were
then centrifuged at 2400 rpm for 5 min. A spectropho-
tometer was used (λ = 632 nm) to measure the absorb-
ance of the supernatant, which was removed using a
straw and placed into a quartz cuvette. Absorbency was
measured using formamide alone as a blank control.
Evans blue (4 mg) was placed into a volumetric flask
and weighed (within the accuracy of 0.1 mg). A total of
100 ml NS was added, and the solution was stirred.
From this solution, 0.3 ml was removed and placed in
5.7 ml of formamide to make the standard buffer solu-
tion. A total of 3 ml of this solution was serially diluted
in tubes, each containing 3 ml of formamide. The amount
of Evans blue in each of the seven tubes was 8, 4, 2, 1, 0.5,0.25 and 0.125 μg per ml. The tubes were capped and
placed into a 54°C water bath for 24 hours. The aforemen-
tioned method to measure absorbance was then used. Lin-
ear regressions were then calculated for the absorbencies
and Evans blue content. The final equation was y = 0.0053 x +
0.0608 (R2 = 0.9833).
We used the formamide method to measure the Evans
blue content in the brain tissue to gauge the severity of
BBB damage. The formula used was as follows: Evans
blue content in brain tissue (μg/g wet brain) = B × form-
amide (ml)/wet weight (g), where B refers to the Evans
blue content of the sample (μg/ml) given by the linear
regression equation according to standard curve.The brain water content measurement
The dry and wet weight method was used to measure
the water content of the brain tissue. The brains were
quickly removed, and a total of 5 mm of brain tissue
surrounding the hematoma was collected. The brain tis-
sue from the posterior-inner part and the posterior-
outside parts of the hematoma were used for testing the
WBC.. First, the weight of the wet tissue was obtained.
The samples were placed in an oven at 100°C for 48 h,
and the dried samples were then weighed. The water con-
tent of the brain tissue was calculated as (wet weight – dry
weight)/wet weight × 100%.Statistical analysis
All data were analyzed using SPSS 11.5. Basic data are
expressed as the mean ± standard deviation (X ± SD). A
repeated measures ANOVA was used to make compari-
sons across the entire time series. When a difference
was detected by ANOVA, a q test or Bonferroni was
used to make comparisons between every two groups. A
p value less than 0.05 was considered to be statistically
significant. Statistical analysis was performed in consult-
ation with the Department of Biostatistics of Guiyang
Medical College.Results
ICH model preparation
Following the blood was infused into the basal ganglia,
the animals were unable to stand up or crawl. The
contralateral extremities were less responsive to noxious
stimulation. Brain CT showed an oval or round hyper-
density in the basal ganglia (Figure 1A), demonstrating
that the ICH model in this study was successful and reli-
able. The ICH model was successfully produced in the
MC group and the MI group. All animals were kept alive
until the experiment was terminated. A total of 60 rab-
bits (30 rabbits in the MC group, and 30 ones in the MI
group) were included in the present study.
Figure 3 The neurofunctional score after MI procedures in
different time window. The neurological deficit score decreased
significantly in different MI subgroups compared with the MC group.
A significant difference of the neurological deficit score in the MI
group was also observed among subgroups. The 6 h group showed
the most favorable outcome as compared with the other
MI subgroups.
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A brain CT showed that there were no significant differ-
ences in the hematoma volume between the MI (0.478±
0.025 ml) and the MC groups (0.480±0.028 ml) after the
ICH model was prepared successfully. The volume of
ICH remained unchanged in the MC group when the
animals experienced a repeated CT scan. However, the
brain CT showed that the hematoma was evacuated
almost completely in all MI subgroups (Figure 1B). A
significant difference in the ICH volume was observed
between the MC group (0.406±0.032 ml) and the MI
group (0.024±0.003 ml), suggesting that the MI proce-
dures could successfully evacuate the intracerebral
hematoma (Figure 2).
The changes of the functional neuroscore
After the model of ICH was established successfully, the
neurological deficit scores increased significantly (8.834
±0.753) compared with the normal reference values (2.000
±0.233), suggesting that the model produces a neurological
deficit. In the MI group, however, the neurological deficit
score decreased in each subgroup two weeks after the MI
procedures were performed to evacuate the ICH (t=8.276,
P<0.05) compared with the MC group. A significant differ-
ence was also observed among different MI subgroups
(F=28.42); the 6–12 hour subgroup displayed a favorable
outcome, suggesting that the MI surgery performed in early
stages after ICH could effectively improve the neurofunc-
tional outcome (Figure 3).
Changes of perihematomal MMP-9 mRNA levels
Compared with the MC group, the quantity of the peri-
hematomal MMP-9 decreased after the hematoma wasFigure 2 The hematoma volume changes after the minimally
invasive surgery. The hematoma volume decreased significantly in
different MI subgroups compared with the MC group, suggesting
that the minimally invasive surgery could effectively evacuate
the ICH.evacuated by the MI procedures. However, the quantity
of perihematomal MMP-9 mRNA was different among
the MI subgroups (F=65.83, P<0.05). The quantity of
perihematomal MMP-9 mRNA was lowest in the 6 h
group, it increased gradually as the time window in-
creased, and it reached the highest level in the 48 h
group. A significant difference was also observed in the
quantity of perihematomal MMP-9 mRNA between all
subgroups in the MI group. The decrease of MMP-9
mRNA level in the 6 h and 12 h subgroups was more
significant compared to that of the other subgroups
(P<0.05), suggesting that the MI procedures for evacu-
ating intracerebral hematoma in early stages could sig-
nificantly reduce the perihematomal MMP-9 mRNA
content (Figure 4).
The changes of BBB permeability and brain water content
The perihematomal Evans blue content (F=93.85, P<0.05)
and BWC (F=1089.50, P<0.05) were significantly changed
across different times within the MI subgroups. Both the
Evans blue and the BWC in each subgroup were de-
creased significantly as compared with the MC group.
Among the MI subgroups, the perihematomal Evans blue
content and the BWC were lowest in the 6 h MI group.
As the time window prolonged, Evans blue and water con-
tent increased and reached their peak in the 48 h MI
group. These results suggested that evacuating the intrace-
rebral hematoma by performing MI procedures within
48 hours after the onset of hemorrhage could reduce the
perihematomal permeability of BBB and decrease cerebral
edema. However, the secondary brain injury became more
serious over time (Figures 5 and 6).
Figure 4 ΔCt values changes of MMP-9 mRNA among different
groups. The ΔCt values of perihematomal MMP-9 mRNA in different MI
subgroups increased significantly as compared with the MC group. A
significant difference of the MMP-9 mRNA was also observed among
subgroups. These results suggested that the MI procedures for
hematoma evacuation could decrease the quantity of MMP-9 mRNA.
Performing the MI procedures in early stages after ICH displayed a
favorable outcome.
Figure 6 Perihematomal BWC changes before and after the
MI procedures. Perihematomal BWC significantly decreased in
different MI subgroups as compared with the MC group. The
perihematomal BWC was varied in different time MI subgroups.
Performing the MI procedures in 6–12 hours after ICH showed
the most favorable results.
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Both BBB permeability and the quantity of MMP-9
mRNA increased in the MC group as the time went on.
The quantity of MMP-9 mRNA of MI subgroups de-
creased significantly compared to the MC group at each
time point. The BBB permeability also decreased corre-
sponding to the decreased quantity of MMP-9. The
quantity of MMP-9 mRNA was lowest in the 6 h group
and highest in the 48 h group, the same changes were
also observed in BBB permeability experiments. AFigure 5 Perihematomal Evans blue content changes before
and after the MI procedures. Perihematomal Evans blue content
significantly decreased after the hematoma was evacuated by the MI
procedures. The perihematomal Evans Blue content was varied in
different time MI subgroups. Performing the MI procedures in 6–12
hours after ICH showed the most favorable results.positive correlation between BBB permeability and the
quantity of MMP-9 mRNA was noted (r=0.982, P<0.05).
Discussions
Intracerebral hemorrhage is a major public-health prob-
lem worldwide [25]. Larger ICHs are typically associated
with high mortality and morbidity, leaving survivors with
severe neurological disability. Many questions remain
unanswered regarding the clinical management of ICH,
although the medical and surgical clinical trials completed
in the past 10 years have refined our understanding of the
goals of ICH management [25]. Recently published studies
have demonstrated that minimally invasive procedures
can successfully evacuate intracerebral hematomas and
improve the outcome of patients [2,4,5,7-11]. Minimally
invasive stereotactic puncture and thrombolysis therapy
have emerged as a promising management strategy for
ICH patients [4,6]. However, the pathophysiological time
window for minimally invasive surgery remains to be elu-
cidated. We are unable to determine this time window in
humans. Large animal models of ICH might provide an
important tool for physicians to observe the effect of min-
imally invasive surgery on the perihematomal changes.
Previously published studies have demonstrated that the
perihematomal pathophysiological changes are associated
with a range of substances such as inflammatory media-
tors, thrombin, hemoglobin breakdown products, oxida-
tive stress, complement, and matrix metalloproteinases
[19,20,26]. Matrix metalloproteinases (MMPs) have been
implicated in BBB disruption and ICH pathogenesis
[27-30]. Several studies have demonstrated that MMP-9
plays an important role in BBB disruption after stroke
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reduce its effect might be beneficial for protecting BBB
from disruption [19,32]. However, MMP inhibition in
spontaneous ICH has solely been made under experimen-
tal conditions, and the basic research has yet to yield sig-
nificant advancements for clinical practice. So, reducing
the production of perihematomal MMP-9 by surgical
procedures for hematoma evacuation might be a better
option. Standard open craniotomy for clearance of intra-
cerebral hematoma often causes damage to the uninjured
brain tissue overlying the hematoma. Minimally invasive
surgery combines the benefits of surgical clot removal
with limited tissue damage and shorter surgery duration
[33]. In the present study, we prepared a rabbit model of
ICH to observe the impact of performing the minimally
invasive procedure at different stages on perihematomal
MMP-9 and its correlation with BBB permeability. The
results showed that perihematomal MMP-9 significantly
decreased after surgery within different time windows for
the evacuation of intracerebral hematoma as compared
with the MC group. The quantity of perihematomal
MMP-9 was different among the MI subgroups. It was
lowest in the 6 h group, and increased gradually as the
time window prolonged, reaching the highest level in
the 48 h group. The decrease of MMP-9 level in the
6 h and 12 h subgroups was more significant compared to
that of the other subgroups, suggesting that the MI
procedures for evacuating intracerebral hematoma in
early stages could significantly reduce the perihematomal
MMP-9 content. The Evans blue content also deceased at
each time point as compared with the MC subgroups,
suggesting that the permeability of BBB were decreased
corresponding to the decreased MMP-9.
Regarding the neurological function, the MI group dis-
played a significant decreased neurological deficit score
two weeks after ICH model preparation compared with
the MC group. The 6–12 hour MI subgroup displayed
a favorable outcome [22,34,35], suggesting that the MI
surgery performed in early stages after ICH could effect-
ively improve the neurofunctional outcome.
Earlier therapeutic time window (0–6 h) would be
helpful in reducing the perihematomal secondary brain
damages and improving neurological functions. But in
clinical practice, the 6–24 h window is usually the earli-
est surgical procedures can be performed. The interval
between the onset of ICH and the ICH evacuation is
prolonged by patient presentation to the hospital, diagnos-
tic work-up, procedures for randomization, arrangements
for stereotactic navigation, and so on. So we selected 6 h
as one of the time points to observe the outcome of
neurofunction and the perihematomal changes.
The effects of performing the minimally invasive sur-
gery in super-early stage (0-6 h) on the outcome of treat-
ment were not observed in the current study. Thiswould be a limitation of the present study. A further
experimental study would be required for observing the
effect of performing the minimally invasive surgery in
3–6 h after ICH to evacuate the hematoma on the out-
come of neurofunction, and the perihematomal patho-
physiological changes.
Conclusions
These data indicated that performing the MI procedures
within 6–12 hours displayed a significant reduction of
MMP-9 and Evans blue content. As the time window
was prolonged, the effects of the MI procedures on
MMP-9 decreased compared with the 6 h–12 h sub-
group. The pathophysiological time window for the MI
surgery might be within 6–12 hours after ICH without
considering the issue of re-hemorrhage.
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